Stem cell 'Educator' shows promise for type 1 diabetes in early trial
NCT ID NCT02624804
First seen Apr 25, 2026 · Last updated May 07, 2026 · Updated 2 times
Summary
This early study tested a new treatment called Stem Cell Educator therapy in 13 adults with type 1 diabetes. The therapy uses a device to 'educate' the patient's own immune cells outside the body, aiming to calm the immune attack on the pancreas. The main goals were to check safety and see if the procedure is feasible, with participants followed for one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hackensack University Medical Center - John Theurer Cancer Center
Hackensack, New Jersey, 07601, United States
Conditions
Explore the condition pages connected to this study.